Search research articles
Contact Us
Filters
Showing results (941-950 of 971) with videos related to
Page
of 98
Sort By:
Human Molecular Genetics
|
December 24, 2016
H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation
Hisashi Hasumi, Yukiko Hasumi, Masaya Baba, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 16, 2010
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis
Maria R Parkhurst, James C Yang, Russell C Langan, et al.
Radiology. Imaging Cancer
|
October 14, 2024
External Validation of a Previously Developed Deep Learning-based Prostate Lesion Detection Algorithm on Paired External and In-House Biparametric MRI Scans
Enis C Yilmaz, Stephanie A Harmon, Yan Mee Law, et al.
The Journal of Urology
|
December 2, 2021
Magnetic Resonance Imaging-Guided Biopsy in Active Surveillance of Prostate Cancer
Adam Kinnaird, Nitin K Yerram, Luke O'Connor, et al.
Inorganic Chemistry
|
June 22, 2017
Ruthenium Complexes are pH-Activated Metallo Prodrugs (pHAMPs) with Light-Triggered Selective Toxicity Toward Cancer Cells
Fengrui Qu, Seungjo Park, Kristina Martinez, et al.
Nature Communications
|
February 15, 2020
A case report of multiple primary prostate tumors with differential drug sensitivity
Scott Wilkinson, Stephanie A Harmon, Nicholas T Terrigino, et al.
BJU International
|
December 10, 2024
A Prostate Imaging-Reporting and Data System version 2.1-based predictive model for clinically significant prostate cancer diagnosis
David G Gelikman, William S Azar, Enis C Yilmaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2012
Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma
Toni K Choueiri, Ulka Vaishampayan, Jonathan E Rosenberg, et al.
The New England Journal of Medicine
|
June 3, 2011
gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma
Douglas J Schwartzentruber, David H Lawson, Jon M Richards, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
Martin Lang, Laura S Schmidt, Kelli M Wilson, et al.
Page
of 98
Search research articles
Search
Showing results (941-950 of 971) with videos related to
Sort By:
Page
of 98
Human Molecular Genetics
|
December 24, 2016
H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation
Hisashi Hasumi, Yukiko Hasumi, Masaya Baba, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 16, 2010
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis
Maria R Parkhurst, James C Yang, Russell C Langan, et al.
Radiology. Imaging Cancer
|
October 14, 2024
External Validation of a Previously Developed Deep Learning-based Prostate Lesion Detection Algorithm on Paired External and In-House Biparametric MRI Scans
Enis C Yilmaz, Stephanie A Harmon, Yan Mee Law, et al.
The Journal of Urology
|
December 2, 2021
Magnetic Resonance Imaging-Guided Biopsy in Active Surveillance of Prostate Cancer
Adam Kinnaird, Nitin K Yerram, Luke O'Connor, et al.
Inorganic Chemistry
|
June 22, 2017
Ruthenium Complexes are pH-Activated Metallo Prodrugs (pHAMPs) with Light-Triggered Selective Toxicity Toward Cancer Cells
Fengrui Qu, Seungjo Park, Kristina Martinez, et al.
Nature Communications
|
February 15, 2020
A case report of multiple primary prostate tumors with differential drug sensitivity
Scott Wilkinson, Stephanie A Harmon, Nicholas T Terrigino, et al.
BJU International
|
December 10, 2024
A Prostate Imaging-Reporting and Data System version 2.1-based predictive model for clinically significant prostate cancer diagnosis
David G Gelikman, William S Azar, Enis C Yilmaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2012
Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma
Toni K Choueiri, Ulka Vaishampayan, Jonathan E Rosenberg, et al.
The New England Journal of Medicine
|
June 3, 2011
gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma
Douglas J Schwartzentruber, David H Lawson, Jon M Richards, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
Martin Lang, Laura S Schmidt, Kelli M Wilson, et al.
Page
of 98